Pitta Shamaka drugs as anti-inflammatory agents in Paripluta Yoni Vyapada

Authors

  • Jitendrakumar Vinaykumar Mishra Department of Prasuti tantra & Stri roga, Dr Vijay Ayurved Medical College, Varanasi, Uttar Pradesh

Keywords:

Paripluta Yoni Vyapada, Pitta Shamaka, Anti-inflammatory, Yoni Vyapada, Ayurvedic gynaecology, Vulvovaginitis, Pelvic inflammatory disease, Chandana, Lodhra, Yashtimadhu, Nimba, Shothahara

Abstract

Background: Paripluta Yoni Vyapada is one of the twenty Yoni Vyapadaas (gynaecological disorders) described in Ayurvedic classics, characterised by excessive vaginal discharge associated with burning sensation, itching, and inflammation — a clinical picture strongly dominated by vitiated Pitta dosha. Contemporary gynaecology identifies this presentation as correlating with conditions such as infective vulvovaginitis, cervicitis, pelvic inflammatory disease (PID), and non-infective inflammatory vaginopathies. Standard modern management relies on antimicrobial and anti-inflammatory pharmacotherapy, while Ayurveda prescribes Pitta Shamaka (Pitta-pacifying) dravyas which inherently possess Shothahara (anti-inflammatory), Jvaraghna (antipyretic), Vishagna (antimicrobial), and Vedanasthapana (analgesic) properties. Objective: To conduct a systematic review of the classical Ayurvedic description of Paripluta Yoni Vyapada, identify the Pitta Shamaka drugs prescribed in classical texts for its management, analyze their anti-inflammatory phytochemical and pharmacological profiles, and correlate these findings with contemporary understanding of vaginal and pelvic inflammatory pathophysiology. Methods: Classical texts including Charaka Samhita, Sushruta Samhita, Ashtanga Hridayam, Harita Samhita, Kashyapa Samhita, Bhavaprakasha, and relevant Nighantu texts were reviewed. A parallel search of PubMed, Scopus, Web of Science, and AYUSH Research Portal (1980-2025) was conducted for pharmacological studies on the identified Pitta Shamaka drugs with specific focus on anti-inflammatory, antimicrobial, and gynaecological applications.  

Downloads

Download data is not yet available.

References

Charaka Samhita (Ayurveda Dipika Commentary by Chakrapanidatta). Chikitsa 30/32-60. Varanasi: Chaukhamba Sanskrit Sansthan; 2014.

Sushruta Samhita (Nibandha Sangraha Commentary by Dalhana). Uttarasthana 38/5-28. Varanasi: Chaukhamba Orientalia; 2012.

Vagbhata. Ashtanga Hridayam (Sarvanga Sundara Commentary). Uttarasthana 33-34. Varanasi: Krishnadas Academy; 2000.

Bhavamishra. Bhavaprakasha Nighantu. Karpuradi Varga; Guduchyadi Varga. Varanasi: Chaukhamba Sanskrit Bhavan; 2010.

Harita. Harita Samhita. Tritiya Sthana 52. Varanasi: Prachya Prakashan; 1985.

Kashyapa. Kashyapa Samhita. Kalpasthana. Varanasi: Chaukhamba Sanskrit Sansthan; 2006.

Sharma PV. Dravyaguna Vijnana. Vol. 2. Varanasi: Chaukhamba Bharati Academy; 2012.

Swamy MK, Akhtar MS, Sinniah UR. Antimicrobial Properties of Plant Essential Oils against Human Pathogens and Their Mode of Action: An Updated Review. Evid Based Complement Alternat Med. 2016;2016:3012462.

Dwivedi V, Shrivastava R, Hussain S, Ganguly C, Bharadwaj M. Comparative anticancer potential of clove (Syzygium aromaticum) -- an Indian spice -- against cancer cell lines of various anatomical origin. Asian Pac J Cancer Prev. 2011;12(8):1989-93.

Baldim V, de Oliveira TC, Neto JS, et al. The anti-inflammatory activity of sandalwood essential oil (Santalum album L.) assessed by in vitro and in vivo models. Molecules. 2021;26(3):526.

Kaur P, Sharma M. Anti-inflammatory and anti-arthritic activities of Vetiveria zizanioides root extract in rodent models. J Ethnopharmacol. 2019;231:1-8.

Sinha S, Mukherjee PK, Mukherjee K, Pal M, Mandal SC, Saha BP. Evaluation of antipyretic potential of Vitex negundo leaf extract. J Ethnopharmacol. 2000;71(1-2):29-33.

Shanmugam MK, Nguyen AH, Kumar AP, Tan BK, Sethi G. Targeted inhibition of tumor proliferation, survival, and metastasis by pentacyclic triterpenoids: potential role in prevention and therapy of human cancers. Cancer Lett. 2012;320(2):158-70.

Nadia R, Faouzi MA, Meddah B, Cherrah Y, Alaoui K. Evaluation of Symplocos racemosa bark anti-inflammatory activity and its mechanisms of action. Int J Pharm Pharm Sci. 2015;7:184-9.

Bhatt S, Kumar V, Jindal DK, Pathak D. Phytochemical and pharmacological review on Symplocos racemosa (Lodhra). Int Res J Pharm. 2011;2(4):43-5.

Bhatt A, Kumar P, Verma S. Anti-inflammatory and analgesic activity of Holarrhena antidysenterica: a review. Asian J Pharm Clin Res. 2013;6(3):12-14.

Suresh V, Mahesh G, Asha VV, Parambil A. Evaluation of anti-inflammatory activity of Holarrhena antidysenterica in carrageenan induced paw edema model. J Pharm Biomed Sci. 2011;11(11):1-4.

Biswas K, Chattopadhyay I, Banerjee RK, Bandyopadhyay U. Biological activities and medicinal properties of neem (Azadirachta indica). Curr Sci. 2002;82(11):1336-45.

Subapriya R, Nagini S. Medicinal properties of neem leaves: a review. Curr Med Chem Anticancer Agents. 2005;5(2):149-56.

Fiore C, Eisenhut M, Krausse R, et al. Antiviral effects of Glycyrrhiza species. Phytother Res. 2008;22(2):141-8.

Jayaprakasha GK, Jaganmohan Rao L, Sakariah KK. Antioxidant activities of curcumin, demethoxycurcumin and bisdemethoxycurcumin. Food Chem. 2006;98(4):720-4.

Aggarwal BB, Harikumar KB. Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases. Int J Biochem Cell Biol. 2009;41(1):40-59.

Tang J, Feng Y, Tsao S, Wang N, Curtain R, Wang Y. Berberine and Coptidis Rhizoma as novel antineoplastic agents: a review of traditional use, pharmacological properties and mechanisms of action. J Ethnopharmacol. 2009;126(1):5-17.

Murray MT, Pizzorno JE. Berberine. In: Textbook of Natural Medicine. 4th ed. St. Louis: Elsevier Churchill Livingstone; 2012:531-538.

Pokare PS, Desale MK, Chaudhari R, Deshmukh P. Study of Yoni Vyapada with special reference to Paripluta Yoni Vyapada. Int J Ayurveda Med. 2019;10(3):271-278.

Hillier SL, Marrazzo JM, Holmes KK. Bacterial vaginosis. In: Holmes KK, Sparling PF, et al., eds. Sexually Transmitted Diseases. 4th ed. New York: McGraw-Hill; 2008:737-68.

Sobel JD. Vulvovaginal candidosis. Lancet. 2007;369(9577):1961-71.

Workowski KA, Bolan GA; Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines. MMWR Recomm Rep. 2015;64(RR-03):1-137.

Garg A, Garg S, Zaneveld LJD, Singla AK. Chemistry and pharmacology of the Citrus bioflavonoid hesperidin. Phytother Res. 2001;15(8):655-69.

Agarwal M, Naik S, Johari M. A review on Yoni Vyapada with special reference to Pitta-Kapha dominant Yoni Roga. J Ayurveda Integr Med Sci. 2021;6(2):234-240.

Published

30-03-2021

How to Cite

Mishra, J. V. (2021). Pitta Shamaka drugs as anti-inflammatory agents in Paripluta Yoni Vyapada. International Journal of Health Sciences, 5(S1), 1662–1680. Retrieved from https://sciencescholar.us/journal/index.php/ijhs/article/view/15920

Issue

Section

Peer Review Articles